RIPK2 and colitis: Consistent with these data obtained in human IBD samples, knockdown of RIPK2 by its specific siRNA protects mice from DSS-induced colitis, whose effects are accompanied by reduced production of IL-6 and TNF-α against TLR ligands in the colonic lamina propria immune cells (80).